Education
About Us
Working with TipRanks
Follow Us
Quantum Biopharma (QNTM)
NASDAQ:QNTM
QNTM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.70 - $35.10
Previous CloseN/A
Volume44.35K
Average Volume (3M)1.02M
Market Cap
$15.25M
Enterprise Value$56.54K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)1.37M
Price to Earnings (P/E)―
Beta0.59
Next Earnings
May 15, 2025EPS Estimate
-0.78Last Dividend Ex-Date
Nov 27, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-14.47
Shares Outstanding2,299,748
10 Day Avg. Volume264,001
30 Day Avg. Volume1,021,902
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Ownership Overview
37.92% Insiders
0.01% Other Institutional Investors
59.59% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
QNTM FAQ
What was Quantum Biopharma’s price range in the past 12 months?
Quantum Biopharma lowest stock price was $2.70 and its highest was $35.10 in the past 12 months.
What is Quantum Biopharma’s market cap?
Quantum Biopharma’s market cap is $15.25M.
When is Quantum Biopharma’s upcoming earnings report date?
Quantum Biopharma’s upcoming earnings report date is May 15, 2025 which is in 29 days.
How were Quantum Biopharma’s earnings last quarter?
Quantum Biopharma released its earnings results on Mar 28, 2025. The company reported -$2.347 earnings per share for the quarter, missing the consensus estimate of -$0.806 by -$1.541.
Is Quantum Biopharma overvalued?
According to Wall Street analysts Quantum Biopharma’s price is currently Overvalued.
Does Quantum Biopharma pay dividends?
Quantum Biopharma pays a Notavailable dividend of $0.412 which represents an annual dividend yield of N/A. See more information on Quantum Biopharma dividends here
What is Quantum Biopharma’s EPS estimate?
Quantum Biopharma’s EPS estimate is -0.78.
How many shares outstanding does Quantum Biopharma have?
Quantum Biopharma has 2,299,748 shares outstanding.
What happened to Quantum Biopharma’s price movement after its last earnings report?
Quantum Biopharma reported an EPS of -$2.347 in its last earnings report, missing expectations of -$0.806. Following the earnings report the stock price went up 2.148%.
Which hedge fund is a major shareholder of Quantum Biopharma?
Currently, no hedge funds are holding shares in QNTM
---
Company Description
Quantum Biopharma
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.
---
QNTM Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering QNTM
1 Year
---